Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)
Year: 2021
Type: article
Study design: Observational Study
Abstract: Infusion-related reactions are common during or after the administration of liposomal drugs. For example, up to 10% of patients treated with Doxil® (pegylated liposomal doxorubicin) experience acut...
Institutions: Washington University in St. Louis, Ochsner Health System, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Tulane University, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center, New York Medical College, Jazz Pharmaceuticals (United States), University of Kansas Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W3161521076